KeyBanc raised the firm’s price target on Baxter to $53 from $52 and keeps an Overweight rating on the shares. The firm is encouraged numbers are starting their climb back up after multiple resets last year, although its capital equipment commentary seemed incrementally negative, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BAX: